Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acarbose add-on to Metformin and Sitagliptin in T2DM
NCT01490918Phase 4Completed
- Sponsor
- The Catholic University of Korea
- Start
- Apr 2012
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of acarbose in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by The Catholic University of Korea. Primary endpoint: Change of Glycated Hemoglobin (HbA1c) From Baseline to 16 Weeks. Started Apr 2012; status: completed.
02
Drugs
acarbose
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01490918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01490918.